Advarra Announces Leadership Structure
Advarra, the company formed by the merger of Chesapeake IRB and Schulman IRB to create the premier provider of IRB, IBC and research compliance services in North America, announces its leadership structure.
Falcon Consulting Announces Name Change to Advarra Consulting
Falcon Consulting Group, Inc., a leading global research quality and compliance company, has changed its name to Advarra Consulting, Inc.
Electronic Platform Integration to Begin in May
Advarra will begin migrating legacy Schulman IRB study information into the Advarra electronic platform in May 2018. Clients will be contacted beginning in March to discuss the migration process and develop a transition plan.
Note to File Re: Statement of Investigator, Form FDA 1572
Effective 2/5, Advarra IRB serves as the IRB providing oversight for the study(ies) listed on 1572s as under Schulman IRB oversight.
Applied Clinical Trials Quotes Advarra President and COO on Electronic Health Records for Clinical Research
Advarra's President and COO Jeff Wendel was quoted in How EHRs Facilitate Clinical Research from Applied Clinical Trials.
Healthcare Businesswomen’s Association Names Robann Cunningham to Cincinnati Chapter Board
Robann Cunningham has been named to the Healthcare Businesswomen’s Association (HBA) Cincinnati Chapter Board as the Director-at-Large for the Programming Committee.
Advarra and TransPerfect Form Strategic Language Services Partnership
TransPerfect Life Sciences announced today that it has been selected as the official language services provider for Advarra.
Effective Date and General Compliance Date for Revised Common Rule Delayed 6 Months
The Department of Health and Human Services (HHS) and 15 other agencies have issued an Interim Final Rule (IFR) that applies a 6 month delay to the effective date and general compliance date of the revisions to the “Federal Policy for the Protection of Human Subjects” (also known as the Common Rule) originally published in the Federal Register on January 19, 2017 (82 FR 7149).
Legal Notice of Name Change
Both Schulman IRB and Chesapeake IRB will retain d/b/a status for an interim period and continue to operate under the current structure.
Integrated Advarra Fee Schedule Now Available
As a part of ongoing integration efforts, Schulman IRB and Chesapeake IRB have developed a joint Fee Schedule for the combined Advarra organization.
Chesapeake IRB and Schulman IRB Merge To Establish Premier Independent Institutional Review Board For Research
Chesapeake IRB and Schulman IRB, the research industry’s two most respected institutional review boards (IRBs), have combined to create Advarra.